Concepedia

B. Sangro

BS

Statistics

Publications

1

Citations

312

H-Index

1

Active since

2024

Affiliations

AstraZeneca (Brazil)(Current)

B. Sangro is an author at AstraZeneca (Brazil) specializing in hepatocellular carcinoma pharmacotherapy, sorafenib therapy, and malignant neoplasms.

Publications per year

2024–2024

1

Publications

1

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text

, , +16

1–1 of 1